Clinical Trial

Phrenic Nerve Infiltration in Neck Pain

Study acronym: PAINOMICS
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 11, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Neck pain frequently present comorbidities in peridiaphragmatic organs. The innervation of these organs include the phrenic nerve. It is known that peridiaphragmatic organs trigger referred pain in the neck area. As well, previous studies have shown that visceral disorders increase sensitization in somatic tissues. This study aims to analyze the ability of phrenic nerve infiltration to diminish sensitization and improve neck symptoms in the absence of neurological, traumatic or infectious pathology that justifies the pain, by means of a randomized controlled trial.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-10-30; most recent amendment 2024-12-05.
Status change: Not Yet Recruiting → Recruiting 2022-11-17
Trial Details
NCT Number NCT05605639
Lead Sponsor University of Seville
Conditions Chronic Neck Pain
Enrollment 60 participants
Start Date 2022-11-17
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-12-11